Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-Qin Liu

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 4, 2015
Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activityGregory D Brown, Qing Shi, George V Delucca, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Journal of Medicinal Chemistry|May 28, 2004
Sultam hydroxamates as novel matrix metalloproteinase inhibitorsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Journal of Medicinal Chemistry|October 19, 2012
Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesisCullen L Cavallaro, Stephanie Briceno, Jing Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|December 4, 2015
Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activityGregory D Brown, Qing Shi, George V Delucca, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Journal of Medicinal Chemistry|May 28, 2004
Sultam hydroxamates as novel matrix metalloproteinase inhibitorsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Journal of Medicinal Chemistry|October 19, 2012
Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesisCullen L Cavallaro, Stephanie Briceno, Jing Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Pageof 4